These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

454 related items for PubMed ID: 28013347

  • 1. MD2 mediates angiotensin II-induced cardiac inflammation and remodeling via directly binding to Ang II and activating TLR4/NF-κB signaling pathway.
    Han J, Zou C, Mei L, Zhang Y, Qian Y, You S, Pan Y, Xu Z, Bai B, Huang W, Liang G.
    Basic Res Cardiol; 2017 Jan; 112(1):9. PubMed ID: 28013347
    [Abstract] [Full Text] [Related]

  • 2. Myeloid Differentiation Protein 2 Mediates Angiotensin II-Induced Liver Inflammation and Fibrosis in Mice.
    Zhang Y, Liu H, Jia W, Qi J, Zhang W, Zhang W, Liang G, Zhang Y, Chen AH.
    Molecules; 2019 Dec 19; 25(1):. PubMed ID: 31861702
    [Abstract] [Full Text] [Related]

  • 3. Angiotensin II induces kidney inflammatory injury and fibrosis through binding to myeloid differentiation protein-2 (MD2).
    Xu Z, Li W, Han J, Zou C, Huang W, Yu W, Shan X, Lum H, Li X, Liang G.
    Sci Rep; 2017 Mar 21; 7():44911. PubMed ID: 28322341
    [Abstract] [Full Text] [Related]

  • 4. Myeloid differentiation protein 2 mediates angiotensin II-induced inflammation and mesenchymal transition in vascular endothelium.
    Qian J, Luo W, Dai C, Wang J, Guan X, Zou C, Chattipakorn N, Wu G, Huang W, Liang G.
    Biochim Biophys Acta Mol Basis Dis; 2021 Mar 01; 1867(3):166043. PubMed ID: 33338595
    [Abstract] [Full Text] [Related]

  • 5. Schisandrin B alleviates angiotensin II-induced cardiac inflammatory remodeling by inhibiting the recruitment of MyD88 to TLRs in mouse cardiomyocytes.
    Xu S, Hu C, Han J, Luo W, Huang L, Jiang Y, Samorodov AV, Wang Y, Huang J.
    Int Immunopharmacol; 2024 Sep 30; 139():112660. PubMed ID: 39018688
    [Abstract] [Full Text] [Related]

  • 6. Heme induces inflammatory injury by directly binding to the complex of myeloid differentiation protein 2 and toll-like receptor 4.
    Lin J, Lin K, Huang L, Jiang Y, Ding X, Luo W, Samorodov AV, Pavlov VN, Liang G, Qian J, Wang Y.
    Toxicol Lett; 2022 Nov 01; 370():15-23. PubMed ID: 36115635
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Arachidonic acid inhibits inflammatory responses by binding to myeloid differentiation factor-2 (MD2) and preventing MD2/toll-like receptor 4 signaling activation.
    Zhang Y, Chen H, Zhang W, Cai Y, Shan P, Wu D, Zhang B, Liu H, Khan ZA, Liang G.
    Biochim Biophys Acta Mol Basis Dis; 2020 May 01; 1866(5):165683. PubMed ID: 31953218
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Angiotensin II-induced hypertension and cardiac hypertrophy are differentially mediated by TLR3- and TLR4-dependent pathways.
    Singh MV, Cicha MZ, Nunez S, Meyerholz DK, Chapleau MW, Abboud FM.
    Am J Physiol Heart Circ Physiol; 2019 May 01; 316(5):H1027-H1038. PubMed ID: 30793936
    [Abstract] [Full Text] [Related]

  • 12. Selective targeting of the TLR4 co-receptor, MD2, prevents colon cancer growth and lung metastasis.
    Rajamanickam V, Yan T, Xu S, Hui J, Xu X, Ren L, Liu Z, Liang G, Wang O, Wang Y.
    Int J Biol Sci; 2020 May 01; 16(8):1288-1302. PubMed ID: 32210720
    [Abstract] [Full Text] [Related]

  • 13. PPARalpha activator fenofibrate modulates angiotensin II-induced inflammatory responses in vascular smooth muscle cells via the TLR4-dependent signaling pathway.
    Ji YY, Liu JT, Liu N, Wang ZD, Liu CH.
    Biochem Pharmacol; 2009 Nov 01; 78(9):1186-97. PubMed ID: 19576184
    [Abstract] [Full Text] [Related]

  • 14. Angiotensin II induces inflammatory response partly via toll-like receptor 4-dependent signaling pathway in vascular smooth muscle cells.
    Ji Y, Liu J, Wang Z, Liu N.
    Cell Physiol Biochem; 2009 Nov 01; 23(4-6):265-76. PubMed ID: 19471094
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of myeloid differentiation factor-2 attenuates obesity-induced cardiomyopathy and fibrosis.
    Fang Q, Wang J, Zhang Y, Wang L, Li W, Han J, Huang W, Liang G, Wang Y.
    Biochim Biophys Acta Mol Basis Dis; 2018 Jan 01; 1864(1):252-262. PubMed ID: 28965884
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Aureusidin derivative CNQX inhibits chronic colitis inflammation and mucosal barrier damage by targeting myeloid differentiation 2 protein.
    Yang Y, Sheng Y, Wang J, Zhou X, Guan Q, Shen H, Li W, Ruan S.
    J Cell Mol Med; 2021 Aug 01; 25(15):7257-7269. PubMed ID: 34184406
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.